 | Relmada Therapeutics (NASDAQ:RLMD) Raised to Buy at Zacks Investment Research
marketbeat.com - January 13 at 4:36 AM |
 | Relmada Therapeutics (NASDAQ:RLMD) Shares Up 5.8%
americanbankingnews.com - January 14 at 3:20 PM |
 | Noteworthy Thursday Option Activity: UPST, RLMD, SAGE
nasdaq.com - January 13 at 5:45 PM |
 | Wall Street Analysts See a 231% Upside in Relmada Therapeutics, Inc. (RLMD): Can the Stock Really Move This High?
finance.yahoo.com - January 12 at 11:42 AM |
| Relmada Therapeutics (NASDAQ:RLMD) Trading 7.3% Higher
americanbankingnews.com - December 23 at 12:41 PM |
| Relmada Therapeutics Announces Closing of Public Offering and Full Exercise of Over-Allotment Option
finance.yahoo.com - December 14 at 9:56 AM |
 | RLMD.O - Relmada Therapeutics Inc Profile | Reuters
reuters.com - December 10 at 6:17 PM |
 | Relmada Stock Falls After Equity Raise Of $150M To Fund Depression Candidate
markets.businessinsider.com - December 9 at 10:20 AM |
| Relmada Therapeutics to Present Data at the 60th Annual Meeting of the American College of Neuropsychopharmacology
finance.yahoo.com - December 1 at 9:59 AM |
| Is Relmada Therapeutics (NASDAQ:RLMD) In A Good Position To Invest In Growth?
finance.yahoo.com - November 29 at 1:17 PM |
| Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results
finance.yahoo.com - November 11 at 6:08 PM |
|
| Relmada Therapeutics to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 11, 2021
finance.yahoo.com - November 4 at 8:13 AM |
| Sage, Biogen Plan to File Zuranolone NDA for MDD in 2022
finance.yahoo.com - October 20 at 1:55 PM |
 | BRIEF-Relmada Therapeutics Provides Regulatory And Development Updates On Ongoing Late-Stage Clinical Program For Rel-1017
msn.com - October 4 at 6:59 PM |
 | Relmada Therapeutics Dextromethadone Hydrochloride Received FDA Orphan Drug Designation on Monday for Treatment of Amyotrophic Lateral Sclerosis
benzinga.com - September 15 at 7:59 PM |
| Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results
finance.yahoo.com - August 10 at 7:25 PM |
| Relmada Therapeutics to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 10, 2021
finance.yahoo.com - August 5 at 5:21 PM |
| What You Need To Know About Relmada Therapeutics, Inc.'s (NASDAQ:RLMD) Investor Composition
nasdaq.com - August 2 at 10:10 PM |
| Down 22.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Relmada Therapeutics, Inc. (RLMD)
finance.yahoo.com - July 30 at 12:53 PM |
| Relmada Therapeutics Gains 6% On Positive Results Of REL-1017
nasdaq.com - July 27 at 12:09 PM |
| Relmada Therapeutics In-Licenses Psilocybin Program From Arbormentis
markets.businessinsider.com - July 22 at 7:59 PM |
| BRIEF-Relmada Therapeutics Announces The Acquisition Of Development And Commercial Rights To Novel Psilocybin And Derivates Program From Arbormentis Llc
msn.com - July 20 at 2:21 PM |
| Relmada Therapeutics, Inc. (RLMD) stock forecast and price target
finance.yahoo.com - June 29 at 12:07 PM |
| Relmada Therapeutics to Present Data at the College on Problems of Drug Dependence 83rd Annual Scientific Meeting
finance.yahoo.com - June 15 at 9:40 AM |
| Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
finance.yahoo.com - May 12 at 6:49 PM |
| Relmada Therapeutics to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 12, 2021
finance.yahoo.com - May 6 at 5:28 PM |
| Relmada Therapeutics Announces Poster Presentations at the 2021 Society of Biological Psychiatry Annual Meeting
finance.yahoo.com - April 29 at 8:32 AM |
| Relmada Therapeutics Announces Participation in the 7th Annual Truist Securities Life Sciences Summit
finance.yahoo.com - April 28 at 9:42 AM |
| Relmada Therapeutics Announces Poster Presentation at the American Society for Pharmacology and Experimental Therapeutics Annual Meeting at Experimental Biology 2021
finance.yahoo.com - April 27 at 8:57 AM |
| Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results
finance.yahoo.com - March 23 at 5:00 PM |
| Relmada Therapeutics, Inc. to Host Earnings Call
finance.yahoo.com - March 23 at 2:40 PM |
 | REL-1017 by Relmada Therapeutics: A NMDA Receptor Antagonists - Global Emerging Insight and Market Forecast Report 2021-2030 - ResearchAndMarkets.com
uk.finance.yahoo.com - March 18 at 8:43 PM |
|
| Relmada Therapeutics to Report Fourth Quarter and Full-Year 2020 Financial Results and Host Conference Call and Webcast on March 23, 2021
finance.yahoo.com - March 18 at 8:43 PM |
| Relmada Therapeutics Announces Participation in the Oppenheimer 31st Annual Healthcare Conference
finance.yahoo.com - March 11 at 12:10 PM |
| Notable Thursday Option Activity: SPCE, CAR, RLMD
nasdaq.com - January 28 at 5:38 PM |
| Will 2021 Continue To Be An Exciting Year For Relmada Therapeutics?
nasdaq.com - January 13 at 8:21 AM |
| Is RLMD A Good Stock To Buy Now?
finance.yahoo.com - December 9 at 4:19 PM |
| Relmada Therapeutics Announces Initiation of Phase 3 Program for REL-1017 as Adjunctive Treatment for Patients with Major Depressive Disorder
finance.yahoo.com - December 7 at 9:12 AM |
| We Think Relmada Therapeutics (NASDAQ:RLMD) Can Afford To Drive Business Growth
finance.yahoo.com - December 3 at 8:42 AM |
| Relmada Therapeutics to Participate in Upcoming Investor Conferences
finance.yahoo.com - November 17 at 9:27 AM |
| Relmada Therapeutics Inc Registered Shs Neutral
markets.businessinsider.com - October 30 at 9:58 AM |
| Relmada Therapeutics, Inc. Common Stock (RLMD)
nasdaq.com - October 23 at 12:02 AM |
| Relmada Therapeutics (RLMD) Stock
markets.businessinsider.com - August 1 at 6:39 PM |
| Oppenheimer: These 2 “Strong Buy” Stocks Are Poised to Surge by Over 80%
finance.yahoo.com - July 17 at 10:41 AM |
| Relmada Therapeutics Announces Uplisting to the Nasdaq Global Select Market®
finance.yahoo.com - July 13 at 1:05 PM |
 | Relmada Therapeutics Inc.
www.marketwatch.com - July 9 at 7:25 PM |
| We're Not Worried About Relmada Therapeutics's (NASDAQ:RLMD) Cash Burn
finance.yahoo.com - June 26 at 8:11 AM |
| Hedge Funds Are Nibbling On Relmada Therapeutics, Inc. (RLMD)
finance.yahoo.com - June 24 at 5:57 PM |
| BRIEF-Relmada Therapeutics Announces Notice Of Allowance For Patent In Canada
www.reuters.com - June 23 at 10:24 AM |
| Relmada Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
finance.yahoo.com - June 9 at 9:21 AM |
| Relmada Therapeutics to Present at the Jefferies 2020 Virtual Healthcare Conference
finance.yahoo.com - May 29 at 9:47 AM |
